Business Standard

Wednesday, December 25, 2024 | 09:20 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19: CSIR-NAL develops non-invasive ventilator in record 36 days

The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre

Health workers wearing protective suits are seen in the premises of LNJP Hospital during the nationwide lockdown, in wake of the coronavirus pandemic, in New Delhi
Premium

Dr Shekhar C Mande, DG CSIR said that CSIR NAL team has enabled a spin-off technology based on its expertise in the aerospace design domain

ANI
In a record time of just 36 days a non-invasive BiPAP Ventilator 'SwasthVayu' has been developed by CSIR - National Aerospace Laboratories (NAL), Bangalore, a constituent of lab of CSIR to treat Covid-19 patients.

Dr Shekhar C Mande, DG CSIR said that CSIR NAL team has enabled a spin-off technology based on its expertise in the aerospace design domain.

The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre.

Jitendra J Jadhav, Director CSIR-NAL said the non-invasive ventilator will be ideal to treat moderate or mid-stage severe Covid-19 patients who do not require intubation and invasive ventilation.

"Based on

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in